Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High Dose Intranasal Oxytocin for Tinnitus
NCT04210310Phase 3Terminated
- Sponsor
- NYU Langone Health
- Start
- Jan 2020
- Primary completion
- May 2022
- Countries
- 1
01
Overview
A Phase 3 trial of oxytocin nasal spray in tinnitus, sponsored by NYU Langone Health. Started Jan 2020; status: terminated.
02
Drugs
oxytocin nasal spray
03
Conditions
tinnitus
Beyond the preview
Go deeper on NCT04210310.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04210310.